Clinical Research Directory
Browse clinical research sites, groups, and studies.
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Sponsor: Universidade do Porto
Summary
The LOOK-UP is an investigator-initiated clinical study with the aim of monitoring the post-marketing safety of the medicine Rinvoq™ (upadacitinib), which is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease. The Marketing Authorisation Holder is AbbVie Deutschland GmbH \& Co. KG.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2024-07-01
Completion Date
2024-12-31
Last Updated
2024-07-15
Healthy Volunteers
No
Conditions
Interventions
Upadacitinib
Exposure to upadacitinib (Rinvoq™) in its different formulations approved by the Portuguese regulatory authority (15, 30, or 45mg extended-release tablets).
Locations (3)
Unidade Local de Saúde de Santo António, E.P.E.
Porto, Portugal
Unidade Local de Saúde de São João, E.P.E.
Porto, Portugal
Unidade Local de Saúde de Gaia/Espinho, E.P.E.
Porto, Portugal